Location: London, United Kingdom
CIK: 0001911876 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Jan 25, 2024
Total Value: $1.848B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| GOOGL | ALPHABET INC | 3,500,000 | $480M | 26.0% | $137.04 | $131.22 | +5.7% | CAP STK CL A | 02079K305 |
| GOOG | ALPHABET INC | 2,180,000 | $300M | 16.3% | $137.82 | $129.52 | +8.0% | CAP STK CL C | 02079K107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 817,832 | $294M | 15.9% | $359.99 | $353.67 | +0.8% | CL B NEW | 084670702 |
| META | META PLATFORMS INC | 750,000 | $254M | 13.8% | $338.99 * | $309.85 | +13.4% | CL A | 30303M102 |
| AAPL | APPLE INC | 1,093,000 | $208M | 11.2% | $190.00 | $182.81 | +4.3% | COM | 037833100 |
| AMZN | AMAZON COM INC | 703,000 | $101M | 5.5% | $143.90 * | $134.00 | +13.4% | COM | 023135106 |
| NFLX | NETFLIX INC | 201,000 | $95.92M | 5.2% | $477.19 * | $43.65 | +11.5% | COM | 64110L106 |
| VRTX | VERTEX PHARMACEUTICALS INC | 200,000 | $70.2M | 3.8% | $351.00 * | $369.42 | +10.1% | COM | 92532F100 |
| CRM | SALESFORCE INC | 191,000 | $44M | 2.4% | $230.35 * | $223.60 | +16.3% | COM | 79466L302 |